get to know us

I1004 Yashika Dooley_419_copy_2

Co-Founder: Yashika Dooley, MD

Dr. Yashika Dooley is an fellowship trained board certified Urogynecologist who is passionate about women's health care and training the next generation of female pelvic surgeons. After completing her undergraduate degree at Howard University, she earned her medical degree at Harvard Medical School. Dr. Dooley then went on to complete her Obstetrics and Gynecology residency in the United States Air Force at Wright Patterson/ Miami Valley Combined Residency Program. She then did fellowship training at Loyola in Female Pelvic Medicine and Reconstructive Surgery and earned a Masters in Clinical Research. She is an Assistant Professor at the Uniformed Services University and has presented national and internationally. She has received numerous awards including APGO Excellence in Teaching, USUHS Clinical Educators Award, Berlex Foundation Junior Faculty Development Award and Bristol Meyer Squibb National Medical Fellow. Her current initiatives include increasing diversity in clinical research and surgery, helping women of color overcome barriers and decrease the gender and racial gap in medicine.

20190114_162428_copy_3

Co-Founder: Marsha Caton, Ph.D.

Marsha earned her Masters and Ph.D in Molecular Genetics from Albert Einstein College of Medicine. Her thesis research was focused on developing gene therapy vectors for the treatment of inherited metabolic liver disorders and examining the genetics of the neurological movement disorder, Dystonia. She earned her Bachelor's degree in Biology at City College of the City University of New York where she began her career in the biomedical sciences as a research assistant. At City College, Marsha's research involved understanding how the anti-cancer drug, bleomycin, mediated tumor cell-death.

Dr. Caton has built her career in drug development having worked for some of the largest and most well-known Pharmaceutical Companies in the industry. She currently works as a Principal Scientist in Immuno-oncology, where she leads drug-approval submission regulatory writing teams. Her work involves evaluation of the efficacy, safety and tolerability of new drug entities for the treatment of various cancers.

Her professional interests include highlighting the importance of clinical research in discovering cures for debilitating diseases, particularly for patients with cancer. She is also very passionate about exposing girls to the biomedical sciences at an early age.